Duquesnoy B, Debiais F, Heuline A, Houvenagel E, Bourgeois P, Alcalay M, Vincent G, Bontoux D, Kahn M F, Delcambre B
Service de Clinique rhumatologique, Hôpital de La Charité, CHRU, Lille.
Presse Med. 1992 Nov 14;21(38):1801-4.
Sciatica caused by intervertebral disc herniation can be treated with intradiscal injection of chymopapain. A search for a cheaper and less allergizing product led to triamcinolone hexacetonide, this procedure being known as "nucleorthesis". The first results at 6 months were encouraging. In 3 centres where triamcinolone hexacetonide was tested with a more than 2 years' follow-up 92 patients could be evaluated. The results obtained were considered satisfactory in 34 patients (36.9 percent), but they were poor in 19 patients (20.6 percent), and 39 patients (42 percent) had to be operated upon within 2 years. Return to surgery took place within the 6 months following nucleorthesis in 18 patients (19.56 percent) and beyond this period in 17 patients (22.8 percent) with degradation of the results. Moreover, calcifications were found in 19 out of 38 patients; they were of varying size, sometimes detected only at computerized tomography, and some of them appeared to produce symptoms. All considered, the failure rates, the number of patients who required surgery and the occurrence of large and sometimes symptomatic calcifications make triamcinolone nucleorthesis unacceptable compared with the recognized percentages of success with papain nucleolysis and surgical operations. For these reasons, we consider that this treatment should be abandoned.
椎间盘突出引起的坐骨神经痛可用木瓜凝乳蛋白酶椎间盘内注射治疗。为寻找一种更便宜且过敏反应较少的产品,人们研发了己酸曲安奈德,此方法被称为“髓核溶解术”。6个月时的初步结果令人鼓舞。在3个对己酸曲安奈德进行了超过2年随访测试的中心,可对92例患者进行评估。结果显示,34例患者(36.9%)疗效满意,19例患者(20.6%)疗效不佳,39例患者(42%)在2年内不得不接受手术。髓核溶解术后6个月内有18例患者(19.56%)再次接受手术,超过此时间段有17例患者(22.8%)再次接受手术,且疗效变差。此外,38例患者中有19例发现钙化;钙化大小不一,有时仅在计算机断层扫描时才能检测到,其中一些似乎会引发症状。综合来看,与公认的木瓜凝乳蛋白酶髓核溶解术和手术成功率相比,己酸曲安奈德髓核溶解术的失败率、需要手术的患者数量以及出现大的且有时引发症状的钙化情况,使其难以被接受。基于这些原因,我们认为这种治疗方法应该被摒弃。